Vascular pharmacotherapy and dementia

Olivier Piguet, Brett Garner*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Citations (Scopus)


The incidence of dementia is increasing dramatically with the ageing population. Increasing evidence indicates that vascular disease is associated with cognitive decline and with the most common form of dementia, Alzheimer's disease (AD). Cardiovascular risk factors such as hyperlipidaemia, hypertension and type 2 diabetes have attracted attention as potential targets in the prevention of dementia. The present review aims to provide a concise overview of the recent advances linking vascular disease with dementia (with a particular focus on AD) and to examine the evidence for efficacy, where possible, for utilising vascular pharmacotherapy as a treatment option for dementia.

Original languageEnglish
Pages (from-to)44-50
Number of pages7
JournalCurrent Vascular Pharmacology
Issue number1
Publication statusPublished - Jan 2010
Externally publishedYes


  • Alzheimer's disease
  • Atherosclerosis
  • Dementia
  • Diabetes
  • Hypertension
  • Lipid-metabolism


Dive into the research topics of 'Vascular pharmacotherapy and dementia'. Together they form a unique fingerprint.

Cite this